Investigators said yesterday that the counterfeit blood-pressure medication scandal that struck Chiayi's God's Heart Hospital last week could have affected other medical facilities.
The number of God's Heart's patients affected has increased to 229, the Department of Health (DOH) said yesterday.
"God's Heart told us they bought 18,000 suspected counterfeit pills and that 14,000 have been been recalled," said Wang Je-chau (王哲超), director of the department's Public Relations Office.
Dai Hsueh-yung (戴雪詠), section chief of the DOH's Bureau of Pharmaceutical Affairs, confirmed that the supplies of Norvasc at three health institutions in Chiayi County and three in Tainan County had been impounded, as the drug came from the same supplier that had serviced God's Heart Hospital.
"At this point we are unable to say categorically whether the drugs are fake, but we do know that they were obtained from Jung-deng pharmaceuticals, the same firm that supplied God's Heart with counterfeit Norvasc," she said.
"Sometimes medical professionals have too much faith in their ability to tell the real thing from fakes," she added.
According to Peng Chiung-hui (彭瓊慧), corporate affairs manager at Pfizer Pharmaceutical Company, there is only one authorized supplier of Norvasc in Taiwan -- Arich Enterprise Co.
"Jung-deng pharmaceuticals only supplied one order of 10 boxes of Norvasc to us through Arich," Peng said.
"People who have older packages of Norvasc are panicking because of the counterfeits," Peng said. "They could be harming themselves unnecessarily by not taking their prescribed blood-pressure medication."
According to the DOH Bureau of Medical Affairs Chief Director Hsueh Jui-yuan (薛瑞元), in addition to criminal liabilities, medical institutions purchasing counterfeit drugs could be fined up to US$250,000 if found to be at fault by the DOH. Affected individuals could also sue hospitals and clinics for damages.
The Centers for Disease Control (CDC) yesterday reported the first case of a new COVID-19 subvariant — BA.3.2 — in a 10-year-old Singaporean girl who had a fever upon arrival in Taiwan and tested positive for the disease. The girl left Taiwan on March 20 and the case did not have a direct impact on the local community, it said. The WHO added the BA.3.2 strain to its list of Variants Under Monitoring in December last year, but this was the first imported case of the COVID-19 variant in Taiwan, CDC Deputy Director-General Lin Ming-cheng (林明誠) said. The girl arrived in Taiwan on
South Korea is planning to revise its controversial electronic arrival card, a step Taiwanese officials said prompted them to hold off on planned retaliatory measures, a South Korean media report said yesterday. A Yonhap News Agency report said that the South Korean Ministry of Foreign Affairs is planning to remove the “previous departure place” and “next destination” fields from its e-arrival card system. The plan, reached after interagency consultations, is under review and aims to simplify entry procedures and align the electronic form with the paper version, a South Korean ministry official said. The fields — which appeared only on the electronic form
The Ministry of Foreign Affairs (MOFA) is suspending retaliation measures against South Korea that were set to take effect tomorrow, after Seoul said it is updating its e-arrival system, MOFA said today. The measures were to be a new round of retaliation after Taiwan on March 1 changed South Korea's designation on government-issued alien resident certificates held by South Korean nationals to "South Korea” from the "Republic of Korea," the country’s official name. The move came after months of protests to Seoul over its listing of Taiwan as "China (Taiwan)" in dropdown menus on its new online immigration entry system. MOFA last week
A bipartisan group of US senators has introduced a bill to enhance cooperation with Taiwan on drone development and to reduce reliance on supply chains linked to China. The proposed Blue Skies for Taiwan Act of 2026 was introduced by Republican US senators Ted Cruz and John Curtis, and Democratic US senators Jeff Merkley and Andy Kim. The legislation seeks to ease constraints on Taiwan-US cooperation in uncrewed aerial systems (UAS), including dependence on China-sourced components, limited access to capital and regulatory barriers under US export controls, a news release issued by Cruz on Wednesday said. The bill would establish a "Blue UAS